Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus

Lupus

Volumn 13, Issue 6, 2004, Pages 463-468

  Fineschi, S ^a   Borghi, M O ^a,b   Riboldi, P ^a,b   Gariglio, M ^c   Buzio, C ^d   Landolfo, S ^e   Cebecauer, L ^f   Tuchynova, A ^f   Rovensky, J ^f   Meroni, P L ^a,b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Natl Inst for Rheumatic Diseases   (Slovakia)

Author keywords

Autoantibodies; SSRP1; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; NUCLEAR PROTEIN; STRUCTURE SPECIFIC RECOGNITION PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IDIOPATHIC AUTOIMMUNE URTICARIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; URTICARIA;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; HIGH MOBILITY GROUP PROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MIDDLE AGED; PREVALENCE; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 3142769084     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1049oa     Document Type: Article

References (36)

1. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunology Today 1996; 17: 163-164.
2. Mohan C, Adams S, Stanik V, Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cell of Lupus. J Exp Med 1993; 177: 1367-1381.
3. Amoura Z, Piette JC, Bach JF, Koutuzov S. The key role of nucleosomes in lupus. Arthritis Rheum 1999; 42: 833-843.
4. Lichota J, Grasser KD. Differential chromatin association and nucleosome binding of the maize HMGA, HMGB, and SSRP1 proteins. Biochemistry 2001; 40: 7860-7867.
5. Grosschedl R, Giese K, Page J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 1994; 10: 94-100.
6. Gariglio M, Ying G, Hertel L, Gaboli M, Clerc RG, Landolfo S. The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. Exp Cell Res 1997; 236: 472-481.
7. Bonaldi T, Langst G, Strohner R, Becker PB, Bianchi ME. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J 2002; 21: 6865-6873.
8. Kokkola R, Sundberg E, Ulfgren AK et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46: 2598-2603.
9. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
10. Stern D, Du Yan S, Fang Yan S, Marie Schmidt A. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002; 54: 1615-1625.
11. Spencer JA, Baron MH, Olson EN. Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRP1. J Biol Chem 1999; 274: 15686-15693.
12. Dyer MA, Hayes PJ, Baron MH. The HMG domain protein SSRP1/PREIIBF is involved in activation of the human embryonic beta-like globin gene. Mol Cell Biol 1998; 18: 2617-2628.
13. Zeng X, Keller DM, Lu H. SSRP1 functions as a co-activalor of the transcriptional activator p63. EMBO J 2002; 21: 5487-5497.
14. Orphanides G, Wu WH, Lane WS, Hampsey M, Reimberg D. The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 1999; 400: 284-288.
15. Cao S, Bendall H, Hicks GG et al. The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos. Mol Cell Biol 2003; 23: 5301-5307.
16. Xiang YY, Wang DY, Sugimura H. Expression of structure-specific recognition protein mRNA in fetal kidney and Fe-nitrotriacetate-induced renal carcinoma in the rat. Cancer Lett 1996; 106: 271-278.
17. Hertel L, DeAndrea M, Bellomo G, Santoro P, Landolfo S, Gariglio M. The HMG protein T160 colocalizes with DNA replication foci and is down regulated during cell differentiation. Exp Cell Res 1999; 250: 313-328.
18. Bustin M, Reisch J, Einck L, Klippel JH. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science 1982; 215: 1245-1247.
19. Ayer LM, Rubin RL, Dixon GH, Fritzler MJ. Antibodies to HMG proteins in patients with drug-induced autoimmunity. Arthritis Rheum 1994; 37: 98-103.
20. Witteman B, Neuer G, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to nonhistone chromosomal proteins HMG1 and HMG2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1990; 33: 1378-1383.
21. Neuer G, Bustin M, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to the chromosomal protein HMG-17 in juvenile rheumatoid arthritis. Arthritis Rheum 1992; 35: 472-474.
22. Ayer LM, Senecal JL, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol 1993; 21: 2071-2075.
23. Morse JH, Zhang Y, Flaster E, Fritzler MJ. Primary pulmonary hypertension: immunogenic response to high-mobility group (HMG) proteins and histone. Clin Exp Immunol 1996; 106: 389-395.
24. Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. J Rheumatol 2001; 29: 90-93.
25. Hahn BH. Animal models of systemic lupus erythematosus. In Wallace DJ, Hahn BH eds. Dubois' lupus erythematosus. Baltimore, Williams & Wilkins, 1997: 339-380.
26. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1276.
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
28. Moroni G, Trendelenburg M, Del Papa N et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 37: 490-498.
29. Mosca M, Bencivelli W, Vitali C, Carrai P, Neri R, Bombardieri S. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000; 9: 445-450.
30. Sabroe RA, Gratton CE, Francis DM, Barr RM, Kobza Blanck A, Greaves MW. The autologus serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermat 1999; 140: 446-452.
31. Cimaz R, Romeo A, Scarano A et al. Prevalence of anticardiolipin, anti-b2-glycoprotein I, and antiprothrombin antibodies in young patients with epilepsy. Epilepsia 2002; 43: 51-59.
32. Avcin T, Cimaz R, Falcini F et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002; 61: 608-611.
33. Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecole expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-766.
34. Krohn NM, Stemmer C, Fojan P, Grimm R, Grasser KD. Protein Kinase CK2 phosphorylates the HMG domain protein SSRP1 inducing the recognition of UV-damaged DNA. J Biol Chem 2003; 278: 12710-12715.
35. Gharavi AE, Mellors RC, Elkon KB. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989; 78: 233-238.
36. Laderach D, Koutouzov S, Bach JF, Yamamoto AM. Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. J Autoimmun 2003; 20: 161-170.